Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.710

-0.080 (-2.11%)

At close: Jul 24, 2026, 4:00 PM EDT

3.779

+0.069 (1.85%)

After-hours: Jul 24, 2026, 7:58 PM EDT

Ironwood Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	361.51	296.15	351.41	442.74	410.6	413.75
Revenue Growth (YoY)	13.80%	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Gross Profit	361.51	296.15	351.41	442.74	410.6	413.75
Selling, General & Admin	70.03	82.26	144.27	158.31	115.99	111.13
Research & Development	89.64	95.14	111.42	116.09	44.27	70.41
Other Operating Expenses	1.66	20.26	2.59	1,114	-	-0.04
Total Operating Expenses	161.33	197.65	258.29	1,388	160.26	181.49
Operating Income	200.18	98.5	93.12	-945.43	250.34	232.26
Interest Income	4.91	4.08	4.47	18.97	9.5	0.73
Interest Expense	-33.82	-32.75	-33.03	-21.63	-7.6	-31.15
Other Non-Operating Income (Expense)	-28.52	-28.28	-27.29	-2.62	2.27	-32.78
Total Non-Operating Income (Expense)	-57.43	-56.95	-55.85	-5.28	4.17	-63.2
Pretax Income	171.47	70.03	65.2	-948.07	252.42	200.66
Provision for Income Taxes	-69.29	-46.01	-64.32	-83.49	-77.36	327.79
Net Income	240.76	116.03	129.52	-864.58	329.78	-127.13
Minority Interest in Earnings	-	-	-	-29.32	-	-
Net Income to Common	102.18	24.02	0.88	-2,034	350.13	1,057
Net Income Growth	-	2629.20%	-	-	-66.87%	895.42%
Shares Outstanding (Basic)	162	162	159	155	154	162
Shares Outstanding (Diluted)	171	163	160	155	186	164
Shares Change (YoY)	6.73%	1.81%	2.99%	-16.57%	13.32%	2.34%
EPS (Basic)	0.64	0.15	0.01	-6.45	1.13	3.26
EPS (Diluted)	0.60	0.15	0.01	-6.45	0.96	3.21
EPS Growth	-	1400.00%	-	-	-70.09%	386.36%
Free Cash Flow	112.21	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Growth	43.10%	22.82%	-43.54%	-33.06%	4.58%	56.67%
Free Cash Flow Per Share	0.66	0.78	0.65	1.18	1.47	1.59
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	55.37%	33.26%	26.50%	-213.54%	60.97%	56.13%
Profit Margin	66.60%	39.18%	36.86%	-195.28%	80.32%	-30.73%
FCF Margin	31.04%	42.89%	29.43%	41.37%	66.64%	63.23%
EBITDA	202.03	100.38	95.14	-943.86	251.76	233.78
EBITDA Margin	55.88%	33.90%	27.07%	-213.19%	61.31%	56.50%
EBIT	200.18	98.5	93.12	-945.43	250.34	232.26
EBIT Margin	55.37%	33.26%	26.50%	-213.54%	60.97%	56.13%
Effective Tax Rate	-40.41%	-65.70%	-98.65%	8.81%	-30.65%	163.36%

SEC Filings: 10-K · 10-Q